$Circle Internet Corp.(CRCL)$ IMHO, while the procedural vote passage represents a significant but measured victory for crypto regulation. While this clears the path for formal voting, the contentious 9-hour debate and Republican holdouts signal underlying concerns about CBDC implications. Circle’s Position: Despite the GENIUS Act’s eventual passage through procedural hurdles, Circle’s stock has shown mixed performance, declining 14.2% from July 1-17 despite current trading at $233. This suggests markets are pricing in execution risks rather than celebrating regulatory clarity. Bitcoin Rally Sustainability: The recent $123,000 peak followed by pullback to $116,000-$119,000 range indicates profit-taking pressure. While institutional adoption
Do You Have Experience Where Stock Gains > Options?
Over the past 10 years, both $NVIDIA(NVDA)$ and $CME Bitcoin - main 2507(BTCmain)$ have delivered returns of up to 30,000%. In our community, we've also seen many users post over 100% gains from holding the underlying stock—some even outperforming options.For example, after TSM’s earnings surge yesterday, one user shared a 222% gain from holding the stock; another posted a 113% return on Nvidia shares! If they had bought before the stock split, the gains would be even higher. Do you have an even greater return?And let’s not forget the recent boom in crypto-related stocks— $SharpLink Gaming(SBET)$ delivered a shocking 269% return on the stock alone, beating i
OSCR Oscar Health is an absolute bargain at these prices and I'm continuing to accumulate as it drops. Price is dropping due to 2x analysts reducing their valuation however the fundamentals remain unchanged. Company continues to beat every profit or revenue target, Has a proven outstanding ceo andoperates in the massive and growing u.s. Private health industry. Oscar Health's most recent revenue reporting, specifically for Q1 2025, shows strong growth. The company reported revenue of $3.05 billion, exceeding analyst expectations of $2.84 billion. Current Market Cap is only $3 billion and with these numbers it is incredibly undervalued. Bear case current fair value $30 Bull case current fair value $50 August 9th is next earnings call and a recent i
$Lululemon Athletica(LULU)$ this is basically the ALO of Canada. Nothing innovative other than their yoga pants. It's Matter of time Shien copy and does it cheaper like the rest of the apparel brands. Basically no growth value at this overprice value. I rather dip into tech stock.
$Coinbase Global, Inc.(COIN)$ , the leading U.S. cryptocurrency exchange, offers compelling reasons for long-term investors to consider it for their portfolios. Here’s why Coinbase could be a smart bet for the future. 1. Crypto Leader Coinbase serves millions, handling massive trading volumes. Its S&P 500 inclusion in May 2025 and Rosenblatt's $470 price target signal strong growth potential. 2. Innovation A $2.9 billion Deribit acquisition and the “everything app” with zero-fee trading and 4% Bitcoin rewards via Coinbase One Card drive expansion. Partnerships in Canada and new tokens in Germany boost global reach. 3. Stable Revenue Revenue from trading, subscriptions, and custody ensures stability, helping
$PropNex(OYY.SI)$ I am treating this as a regular source of income. >4% dividends for a Singapore stock is not bad. This is coupled with gradual increase in share price. Owning this stock is like having a goose that lays golden eggs 🤗
$Tesla Motors(TSLA)$ Tesla is scheduled to release its Q2 2025 earnings report on *July 23*, amid a backdrop of declining vehicle deliveries, margin compression, and heightened competition. Here's an analysis of the outlook and potential trading strategies: --- 📉 Q2 2025 Earnings Outlook - *Deliveries*: Tesla delivered *384,122 vehicles* in Q2, marking a *13.5% year-over-year decline* and missing Wall Street's estimate of 390,000 units. [1] - *Revenue*: Analysts anticipate a revenue drop of approximately *11%*, bringing it down to *22.72 billion* from the same quarter last year. [2] - *Earnings Per Share (EPS)*: Projected at *0.42*, representing a *19% decrease* from the previous year. [2] - *Automotive Gross
Elevance Stock Falls 11% After Earnings: What It Means for UnitedHealth and Other Insurers — Should You Buy the Dip?
$Elevance Health(ELV)$ Shares of Elevance Health (NYSE: ELV), the nation’s second-largest health insurer, slipped sharply after the company reported disappointing second-quarter earnings and lowered its full-year outlook. The stock fell nearly 5% in early trading as investors digested weaker-than-expected profitability and management’s acknowledgment of rising medical costs pressuring margins. For long-term investors, however, the question is not merely about the latest quarterly miss, but whether Elevance’s competitive position and long-term growth prospects remain intact. Could this pullback present a buying opportunity in a high-quality company, or are there deeper issues lurking beneath the surface? This article takes a closer look at Elevance’
Making Trade Wars Great Again: Will Markets Swallow Trump’s 30% EU Tariffs?
$S&P 500(.SPX)$ The trade war rhetoric that once roiled global markets has returned to center stage. Former President Donald Trump, now the Republican frontrunner and widely expected to reclaim the White House in November, announced that his administration would impose a sweeping 30% tariff on all European Union imports if Brussels “doesn’t play fair” on trade. The bold pronouncement — which came at a campaign rally in Ohio last week and was quickly clarified by his advisors as a “serious policy intention, not mere hyperbole” — sent shockwaves through equities, commodities, and currency markets. While the EU has yet to formally respond, investors are already grappling with the potential consequences of a renewed transatlantic trade war. What w
Lucid Stock Soars 36% on Robotaxi Partnership With Uber, Nuro: A Turning Point or a Mirage?
$Lucid Group Inc(LCID)$ In a surprise move that electrified markets, shares of Lucid Group (NASDAQ: LCID) surged 36% this week after the luxury electric vehicle maker announced a high-profile partnership with ride-hailing giant Uber and autonomous delivery startup Nuro to develop and deploy robotaxi services. The partnership marks Lucid’s most ambitious strategic pivot to date as it seeks to expand beyond the luxury EV market and into the autonomous mobility ecosystem — a space investors have long speculated it might enter. For a company that has struggled with production setbacks, cash burn, and wavering investor confidence, the sudden stock rally has reignited debate about Lucid’s long-term prospects. Is this the inflection point that puts Lucid
Crypto Bills Ignite the Market: Circle or Coinbase to Lead the Charge?
The crypto market is ablaze as Ethereum (ETH) rockets to $3,600, its highest since January 7, 2025, and Solana (SOL) surges 21% in a month to $302.50. The U.S. House’s passage of three landmark bills—GENIUS Act, CLARITY Act, and Anti-CBDC Surveillance State Act—on July 17, 2025, during “Crypto Week” has supercharged crypto stocks, with Circle Internet Group (CRCL) and Coinbase Global (COIN) leading the pack. CRCL, issuer of the USDC stablecoin, soared 17% to $237, while COIN, the top U.S. crypto exchange, climbed to $398.20. With Bitcoin at $123,000 and regulatory clarity fueling optimism, investors are asking: Which stock—CRCL or COIN—offers the best shot at capitalizing on this bull market? Is it too late to jump in? This report dives into the crypto bills’ impact, compares CRCL and COIN
NVIDIA’s $10 Trillion Quest: Still the Ultimate 10x Bagger?
NVIDIA ( $NVIDIA(NVDA)$ ) has cemented its place as the world’s most valuable company, boasting a $4.17 trillion market cap on July 15, 2025, outpacing Microsoft ($3.76 trillion) and Apple ($3.12 trillion). With a staggering 1,596% stock price surge over the past five years, investors are buzzing: Can NVIDIA soar to a $10 trillion valuation by 2030, and is it still the go-to 10x bagger? Analysts like Wedbush and Loop Capital are eyeing stock prices as high as $250 by year-end, while long-term forecasts range from $500 to $1,770 by 2029. This report dives into NVIDIA’s growth drivers, the feasibility of a $10 trillion market cap, alternative 10x baggers, and strategic investment approaches to capitalize on this AI-driven juggernaut while managing r
Centene Corporation: Resilient in a Shifting Policy Landscape — But Is It a Buy, Sell or Hold?
$Centene(CNC)$ Centene Corporation (NYSE: CNC) has long been a bellwether for the U.S. managed care industry, particularly among firms serving government-sponsored health programs like Medicaid, Medicare, and the Affordable Care Act (ACA) marketplaces. As one of the nation’s largest Medicaid managed care organizations, Centene has benefited from rising enrollment and state outsourcing of Medicaid administration. Yet 2025 has brought renewed questions about the future of government healthcare funding and managed care margins, as well as new uncertainty surrounding the impact of President Donald Trump’s policy initiatives in his second term. Against this backdrop, Centene stock has underperformed the broader market, leaving investors to wonder: is no